A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab
n.
Saved in:
Main Authors: | Mauro Passucci, Francesca Fazio, Maria Teresa Petrucci |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2023-01-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/5203 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An unusual cause of anemia and encephalopathy
by: Sanjeev Kumar Sharma, et al.
Published: (2015-04-01) -
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens
by: Danilo De Novellis, et al.
Published: (2024-07-01) -
Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?
by: Davor Galusic, et al.
Published: (2025-01-01) -
Economic Evaluation of Adding Daratumumab to Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma
by: Yi L, et al.
Published: (2024-11-01) -
Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis
by: Hua Jiang, et al.
Published: (2024-12-01)